Announced
Synopsis
Molex, a manufacturer of electronic, electrical, and fiber optic connectivity systems, agreed to acquire Vectura Group, a British pharmaceuticals company which develops inhaled medicines and makes inhaler devices, from Philip Morris International, an American multinational tobacco company, for £298m. “The acquisition of Vectura is the latest step in building an industry-leading capability in medical. It also demonstrates Molex’s commitment to acquiring opportunities to better serve market needs across our portfolio," Joe Nelligan, Molex CEO.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Sort
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.